HOME >> BIOLOGY >> NEWS
Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment

Researchers from the University of Chicago and Boston Biomedical Research Institute have described the three-dimensional structure of edema factor, one of the three toxins that make anthrax so deadly. This finding, published in the January 24 issue of Nature, is a crucial step toward designing drugs to block the harmful effects of anthrax and perhaps other bacterial toxins.

Although antibiotics can kill the bacteria, anthrax produces toxins that can cause death even after the bacteria have been eradicated. Since some forms of anthrax infection produce few symptoms until the disease is advanced, physicians need better drugs to counteract these toxins.

"Knowing the structure of edema factor and how it works allows us to design drugs that can block its effects," said Wei-Jen Tang, Ph.D., associate professor in the Ben May Cancer Research Laboratories at the University of Chicago and director of the study.

Anthrax produces three toxins that work together. One, called protective antigen, allows the other two to enter target cells. The second, lethal factor, destroys cells of the immune system. When immune cells die they release inflammatory agents that can cause septic shock, leading to death. The structure for protective antigen was published in February, 1997, and that of lethal factor in November, 2001.

The structure of the third toxin, called edema factor because
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
23-Jan-2002


Page: 1 2 3 4

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Third set of awards are announced under interagency biodiversity program
3. Large brains not required? Third and smallest skull of first Eurasians reported in Science
4. Rutgers scientists create high-protein corn with Third World potential
5. Third Wave scientists publish advance in gene expression monitoring with revolutionary RNA Invader Assay
6. University Of Kentucky Researcher Awarded MERIT Extension For Study Of Third World Killer
7. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
8. Fortified Drink Improves Third World Nutrition
9. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
10. Building the whole cell from pieces
11. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?

Post Your Comments:
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a leader ... million in Series A1 funding led by UK-based Eurovestech. ... participated in the investment round. "We are ... community adopts next-generation sequencing and seeks new approaches for ... Reid Robison , MD MBA, and CEO of Tute ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
(Date:12/19/2014)... N.Y. , Dec. 18, 2014 Egenix, Inc. ... has been elected Chairman of the Board, to succeed ... and CEO, but will continue as a member of the ... he has added to the company over almost twenty years, ... The Board of Directors has established a Search Committee ...
(Date:12/17/2014)... USA (PRWEB) December 16, 2014 ... manager at Philipps- Universität Marburg’s Department of Physics, ... photonics, in the newly released SPIE Women ... never be too shy to ask questions.” , ... technology, engineering, and mathematics) occupations ranging from university ...
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... Md. , Dec. 17, 2014 CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a primary commercial focus ... it has been granted a Type C meeting with ... the meeting will be held in February 2015.  During ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
Cached News: